Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent.

Pognan F, Saucier JM, Paoletti C, Kaczmarek L, Nantka-Namirski P, Mordarski M, Peczynska-Czoch W.

Biochem Pharmacol. 1992 Dec 1;44(11):2149-55.

PMID:
1335251
2.

Stimulation by gamma-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II.

Fossé P, René B, Saucier JM, Nguyen CH, Bisagni E, Paoletti C.

Biochem Pharmacol. 1990 Feb 15;39(4):669-76.

PMID:
2154990
3.

Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.

Zwelling LA, Mayes J, Hinds M, Chan D, Altschuler E, Carroll B, Parker E, Deisseroth K, Radcliffe A, Seligman M, et al.

Biochemistry. 1991 Apr 23;30(16):4048-55.

PMID:
1850298
4.

The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.

Rene B, Fosse P, Khelifa T, Jacquemin-Sablon A, Bailly C.

Mol Pharmacol. 1996 Feb;49(2):343-50.

PMID:
8632768
5.

Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

Tewey KM, Chen GL, Nelson EM, Liu LF.

J Biol Chem. 1984 Jul 25;259(14):9182-7.

6.

The beta-carboline analog Mana-Hox causes mitotic aberration by interacting with DNA.

Tu LC, Chen CS, Hsiao IC, Chern JW, Lin CH, Shen YC, Yeh SF.

Chem Biol. 2005 Dec;12(12):1317-24.

7.

Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyellipticine resistant cells.

Charcosset JY, Saucier JM, Jacquemin-Sablon A.

Biochem Pharmacol. 1988 Jun 1;37(11):2145-9.

PMID:
2837227
8.
9.
10.

Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.

Pommier Y, Kerrigan D, Schwartz RE, Swack JA, McCurdy A.

Cancer Res. 1986 Jun;46(6):3075-81.

11.

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.

Multon E, Riou JF, LeFevre D, Ahomadegbe JC, Riou G.

Biochem Pharmacol. 1989 Jul 1;38(13):2077-86.

PMID:
2544183
12.

Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.

Pommier Y, Schwartz RE, Zwelling LA, Kerrigan D, Mattern MR, Charcosset JY, Jacquemin-Sablon A, Kohn KW.

Cancer Res. 1986 Feb;46(2):611-6.

13.

Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.

Pommier Y, Schwartz RE, Zwelling LA, Kohn KW.

Biochemistry. 1985 Nov 5;24(23):6406-10.

PMID:
3002439
16.

Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.

Bojanowski K, Lelievre S, Markovits J, Couprie J, Jacquemin-Sablon A, Larsen AK.

Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3025-9.

17.

Topoisomerase II mediated DNA lesions induced by acridine-4-carboxamide and 2-(4-pyridyl)quinoline-8-carboxamide.

Woynarowski JM, McCarthy K, Reynolds B, Beerman TA, Denny WA.

Anticancer Drug Des. 1994 Feb;9(1):9-24.

PMID:
8141968
18.

Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II.

Zwelling LA, Hinds M, Chan D, Mayes J, Sie KL, Parker E, Silberman L, Radcliffe A, Beran M, Blick M.

J Biol Chem. 1989 Oct 5;264(28):16411-20.

19.

Induction of apoptotic cell death by DNA topoisomerase II inhibitors.

Negri C, Bernardi R, Donzelli M, Scovassi AI.

Biochimie. 1995;77(11):893-9.

PMID:
8824770
20.

The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.

Larsen AK, Grondard L, Couprie J, Desoize B, Comoe L, Jardillier JC, Riou JF.

Biochem Pharmacol. 1993 Oct 19;46(8):1403-12.

PMID:
8240389

Supplemental Content

Support Center